What is it about?
Male breast cancer is a rare and little-known pathology. Its incidence is increasing in industrialized countries. There are many similarities with cancer in women, but there are also particularities in management, linked to patient age, the presence of co-morbidities, longer diagnosis times and smaller breast volume.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Total mastectomy with axillary curage remains the gold standard. Sentinel node sampling is a promising option for early-stage management. Adjuvant irradiation is generally systematic, and tamoxifen remains the hormone therapy of choice.
Perspectives
Male breast cancer is a rare condition, accounting for around 1% of all breast cancers and less than 1% of all male neoplasia. [1] The incidence of this male pathology has risen steadily from 0.86/100,000 to 1.06/100,000 over the past three decades. [2]
Acquire Publications
Read the Original
This page is a summary of: Male Breast Cancer: About 1 Case, Journal of Case Reports and Medical History, July 2025, Acquire Publications LLC,
DOI: 10.54289/jcrmh2500133.
You can read the full text:
Contributors
The following have contributed to this page
